t*r
3 楼
璇锋槑绀猴紝涓嶆噦銆br />
浣犳剰鎬濇槸涓嶈璺熼锛br />
鍗佷竴鏈堝垵鍒扮幇鍦ㄥ凡缁
忕炕浜嗕笁鍊嶄簡銆br />
銆鍦Justin3(璧甸鐕閲囨槗鐧惧悎*璧电湡*鏉ㄦ埇*鑻忔槑鏄鐗′腹鑺憋拷)
鐨勫ぇ浣滀腑鎻愬埌: 銆br />
: 鍏ラ棬32姝ャ銆傘
浣犳剰鎬濇槸涓嶈璺熼锛br />
鍗佷竴鏈堝垵鍒扮幇鍦ㄥ凡缁
忕炕浜嗕笁鍊嶄簡銆br />
銆鍦Justin3(璧甸鐕閲囨槗鐧惧悎*璧电湡*鏉ㄦ埇*鑻忔槑鏄鐗′腹鑺憋拷)
鐨勫ぇ浣滀腑鎻愬埌: 銆br />
: 鍏ラ棬32姝ャ銆傘
m*c
4 楼
如果被收购还会涨,如果没有收购会暴跌。50%。
t*r
5 楼
没说要收购呀,就说报告收入好了。
Here are three stocks with continued technical momentum in the days and
weeks after strong earnings releases.
Clovis Oncology Inc. CLVS, 16.97% jumped 75 cents to $7.76 on 8.1 million
shares traded Thursday. The move continued the stock’s run-up following the
biotech company’s better-than-expected earnings release two weeks ago. The
stock closed right above lateral resistance, and next target is the rising
channel top near $9-$9.25.
: 如果被收购还会涨,如果没有收购会暴跌。50%。
【在 m******c 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: 如果被收购还会涨,如果没有收购会暴跌。50%。
Here are three stocks with continued technical momentum in the days and
weeks after strong earnings releases.
Clovis Oncology Inc. CLVS, 16.97% jumped 75 cents to $7.76 on 8.1 million
shares traded Thursday. The move continued the stock’s run-up following the
biotech company’s better-than-expected earnings release two weeks ago. The
stock closed right above lateral resistance, and next target is the rising
channel top near $9-$9.25.
: 如果被收购还会涨,如果没有收购会暴跌。50%。
【在 m******c 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: 如果被收购还会涨,如果没有收购会暴跌。50%。
t*r
6 楼
今天加仓了CLVS, 看上去太强势了。
短期看到16
短期看到16
相关阅读